Amitriptyline 10 & 50mg recall in Canada: NDMA and NNORT impurity
In plain language
This recall involves Amitriptyline 10mg and 50mg tablets sold in Quebec, Canada. It's being recalled due to exceeding acceptable limits for NDMA and NNORT impurities. Continue taking your medication and contact your healthcare provider to discuss treatment options.
What to do
- Continue taking your medication.
- Contact your healthcare provider to discuss treatment options if you are using a recalled product.
- Contact your healthcare provider if you have taken a recalled product and are concerned about your health.
- Ask your pharmacist if you are unsure if the product you are taking has been recalled.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
AMITRIPTYLINE 10mg
Lot: 632627, 633441, 638164
AMITRIPTYLINE 50mg
Lot: 633436
Why this matters
Contamination
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: 632627, 633441, 638164, 633436
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Contamination
What should consumers do?
Continue taking your medication. Contact your healthcare provider to discuss treatment options if you are using a recalled product. Contact your healthcare provider if you have taken a recalled product and are concerned about your health. Ask your pharmacist if you are unsure if the product you are taking has been recalled.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Contamination
When was this product recalled?
This product was recalled on August 16, 2023.
Is the AMITRIPTYLINE brand affected by this recall?
Yes, AMITRIPTYLINE products are affected by this recall. This recall involves Amitriptyline 10mg and 50mg tablets sold in Quebec, Canada. It's being recalled due to exceeding acceptable limits for NDMA and NNORT impurities. Continue taking your medication and contact your healthcare provider to discuss treatment options.